Flexible two-stage design with sample size reassessment for survival trials

Statistics in Medicine

Volumn 26, Issue 27, 2007, Pages 5002-5013

  Desseaux, Kristell ^a   Porcher, R ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Flexible two stage designs; Sample size reassessment; Survival trials

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; CONTROLLED STUDY; HAZARD RATIO; MATHEMATICAL COMPUTING; METHODOLOGY; SAMPLE SIZE; SIMULATION; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC ERROR; THERAPY EFFECT;

CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; COMPUTER SIMULATION; HUMANS; RESEARCH DESIGN; SAMPLE SIZE; SURVIVAL ANALYSIS;

EID: 35948935069     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2966     Document Type: Conference Paper

References (31)

1. Whitehead J. The Design and Analysis of Sequential Clinical Trials (2nd edn). Ellis Horwood Ltd.: Chichester, 1992.
2. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50:1029-1041.
3. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
4. Posch M, Bauer P. Interim analysis and sample size reassessment. Biometrics 2000; 56:1170-1176.
5. Schäfer H, Müller HH. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections. Statistics in Medicine 2001; 20:3741-3751.
6. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Statistics in Medicine 2003; 22:953-969.
7. Jennison C, Turnbull B. Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine 2003; 22:971-993.
8. Li G, Shih W, Wang Y. Two-stage adaptive design for clinical trials with survival data. Journal of Biopharmaceutical Statistics 2005; 15:707-718.
9. Lawrence J. Strategies for changing the test statistics during a clinical trials. Journal of Biopharmaceutical Statistics 2002; 12:193-205.
10. Kieser M, Schneider B, Friede T. A bootstrap procedure for adaptive selection of the test statistic in flexible two-stage designs. Biometrical Journal 2002; 44:641-652.
11. Kieser M, Bauer P, Lehmacher W. Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biometrical Journal 1999; 41:261-277.
12. Hommel G. Adaptive modifications of hypotheses after an interim analysis. Biometrical Journal 2001; 43:581-589.
13. Bauer P, Röhmel J. An adaptive method for establishing a dose-response relationship. Statistics in Medicine 1995; 14:1595-1607.
14. Bauer P, Röhmel J, Maurer W, Hothorn L. Testing strategies in multi-dose experiments including active control. Statistics in Medicine 1998; 17:2133-2146.
15. Bauer P, Kieser M. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 1999; 18:1833-1848.
16. Brannath W, König F, Bauer P. Estimation in flexible two stage designs. Statistics in Medicine 2006; 25:3366-3381.
17. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Statistics in Medicine 1984; 3:409-422.
18. Li C, Shih W, Xie T, Lu J. A sample size adjustment procedure for clinical trials based on conditional power. Biostatistics 2002; 3:277-287.
19. Brannath W, Posch M, Bauer P. Recursive combination tests. Journal of the American Statistical Association 2002; 97:236-244.
20. Tsiatis AA. The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time. Biometrika 1981; 68:311-315.
21. Tsiatis AA. Repeated significance testing for a general class of statistics used in censored survival analysis. Journal of the American Statistical Association 1982; 77:855-861.
22. Sellke T, Siegmund D. Sequential analysis of the proportional hazards model. Biometrika 1982; 70:315-326.
23. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Statistics in Medicine 1982; 1:121-129.
24. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983; 39: 499-503.
25. Whitehead J, Whitehead A, Todd S, Bolland K, Sooriyarachchi MR. Mid-trial design reviews for sequential clinical trials. Statistics in Medicine 2001; 20:165-176.
26. Denne J. Sample size recalculation using conditional power. Statistics in Medicine 2001; 20:2645-2660.
27. Tsiatis A, Metha C. On the efficiency of the adaptive design for monitoring clinical trials. Biometrika 2003; 90:367-378.
28. Bauer P, Posch M. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections, by H. Schäffer and H.-H. Müller. Statistics in Medicine 2001; 20:3741-3751; Statistics in Medicine 2004; 23:1333-1334; Authors Reply 1334-1335.
29. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986; 42:507-519.
30. Porcher R, Lévy V, Chevret S. Sample size correction for treatment crossovers in randomized clinical trials with a survival endpoint. Controlled Clinical Trials 2002; 23:650-661.
31. Gould A, Shih W. Modifying the design of ongoing trials without unblinding. Statistics in Medicine 1998; 17:89-100.